These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 34003156)

  • 1. Comparison of Peripheral Neurectomy vs. Medical Treatment for Migraine: A Randomized Controlled Trial.
    Bajaj J; Doddamani R; Chandra SP; Ratre S; Parihar V; Yadav Y; Sharma D
    Neurol India; 2021; 69(Supplement):S110-S115. PubMed ID: 34003156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled surgical trial of the treatment of migraine headaches.
    Guyuron B; Reed D; Kriegler JS; Davis J; Pashmini N; Amini S
    Plast Reconstr Surg; 2009 Aug; 124(2):461-468. PubMed ID: 19644260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial.
    Kashipazha D; Ghadikolaei HS; Siavashi M
    Curr Clin Pharmacol; 2017; 12(1):55-59. PubMed ID: 28356053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
    Mathew NT; Jaffri SF
    Headache; 2009; 49(10):1466-78. PubMed ID: 19912346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Prospective Randomized Outcomes Comparison of Two Temple Migraine Trigger Site Deactivation Techniques.
    Guyuron B; Harvey D; Reed D
    Plast Reconstr Surg; 2015 Jul; 136(1):159-165. PubMed ID: 25829156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study.
    Dodick DW; Silberstein SD; Reed KL; Deer TR; Slavin KV; Huh B; Sharan AD; Narouze S; Mogilner AY; Trentman TL; Ordia J; Vaisman J; Goldstein J; Mekhail N
    Cephalalgia; 2015 Apr; 35(4):344-58. PubMed ID: 25078718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of a double-blind, placebo-controlled, randomized study for repetitive sphenopalatine blockade with bupivacaine vs. saline with the Tx360 device for treatment of chronic migraine.
    Cady RK; Saper J; Dexter K; Cady RJ; Manley HR
    Headache; 2015 Apr; 55(4):529-42. PubMed ID: 25828648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional outcomes between headache surgery and targeted botox injections: A prospective multicenter pilot study.
    Janis JE; Hehr J; Huayllani MT; Khansa I; Gfrerer L; Kavanagh K; Blake P; Gokun Y; Austen WG
    JPRAS Open; 2023 Dec; 38():152-162. PubMed ID: 37920284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two ultrasound-guided techniques for greater occipital nerve injections in chronic migraine: a double-blind, randomized, controlled trial.
    Flamer D; Alakkad H; Soneji N; Tumber P; Peng P; Kara J; Hoydonckx Y; Bhatia A
    Reg Anesth Pain Med; 2019 May; 44(5):595-603. PubMed ID: 30886069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topiramate treatment of chronic migraine: a randomized, placebo-controlled trial of quality of life and other efficacy measures.
    Silberstein S; Lipton R; Dodick D; Freitag F; Mathew N; Brandes J; Bigal M; Ascher S; Morein J; Wright P; Greenberg S; Hulihan J
    Headache; 2009 Sep; 49(8):1153-62. PubMed ID: 19719543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ability to Cope with Pain Puts Migraine Surgery Patients in Perspective.
    Gfrerer L; Lans J; Faulkner HR; Nota S; Bot AGJ; Austen WG
    Plast Reconstr Surg; 2018 Jan; 141(1):169-174. PubMed ID: 29280878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Greater occipital nerve excision for occipital neuralgia refractory to nerve decompression.
    Ducic I; Felder JM; Khan N; Youn S
    Ann Plast Surg; 2014 Feb; 72(2):184-7. PubMed ID: 24322636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: three double-blind, randomized, placebo-controlled trials.
    Lipton RB; Stewart WF; Ryan RE; Saper J; Silberstein S; Sheftell F
    Arch Neurol; 1998 Feb; 55(2):210-7. PubMed ID: 9482363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Migraine Surgery: A Systematic Review and Meta-analysis of Outcomes and Complication Rates.
    ElHawary H; Barone N; Baradaran A; Janis JE
    Ann Surg; 2022 Feb; 275(2):e315-e323. PubMed ID: 35007230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized, Double-Dummy, Emergency Department-Based Study of Greater Occipital Nerve Block With Bupivacaine vs Intravenous Metoclopramide for Treatment of Migraine.
    Friedman BW; Irizarry E; Williams A; Solorzano C; Zias E; Robbins MS; Harrilal MA; Del Valle M; Bijur PE; Gallagher EJ
    Headache; 2020 Nov; 60(10):2380-2388. PubMed ID: 32981043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of greater occipital nerve blockade in chronic migraine: A placebo-controlled study.
    Gul HL; Ozon AO; Karadas O; Koc G; Inan LE
    Acta Neurol Scand; 2017 Aug; 136(2):138-144. PubMed ID: 27910088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the efficacy of peripheral nerve block alone in episodic and chronic migraine patients.
    Evcili G; Yabalak A
    Arq Neuropsiquiatr; 2023 Aug; 81(8):734-739. PubMed ID: 37536366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.
    Aurora SK; Dodick DW; Diener HC; DeGryse RE; Turkel CC; Lipton RB; Silberstein SD
    Acta Neurol Scand; 2014 Jan; 129(1):61-70. PubMed ID: 24107267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.